Paul Buckman - 03 Apr 2026 Form 4 Insider Report for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

Reporting relationship: Director
Issuer ticker: NMTC
Reported as of: 03 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Apr 2026, 13:28:19 UTC
Prior SEC filing: 02 Apr 2026
Next SEC filing: 29 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Emily Johns, by Power of Attorney

Key filing fact

Paul Buckman filed Form 4 for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) on 07 Apr 2026.

Key facts

This page summarizes Paul Buckman's Form 4 filing for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Apr 2026, 13:28.

Change

Previous filing in this sequence was filed on 02 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001215243 Primary reporting owner

BUCKMAN PAUL

Relationship: Director
Address: 7599 ANAGRAM DR., EDEN PRAIRIE
Signature: /s/ Emily Johns, by Power of Attorney
Signature date: 07 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NMTC transaction

Common Stock

Award

Transaction value
Shares: +41,929
Change %: +31%
Price: $0.000000^*
Shares after: 178,733
Date: 03 Apr 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NMTC transaction Derivative

Option to Purchase Common Stock

Award

Transaction value
Shares: +26,036
Change %
Price: $0.000000^*
Shares after: 26,036
Date: 03 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 26,036
Exercise price: $0.7950
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Footnote F2

The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.